Articles by Disease (Brain Damage, Chronic)

Inhibitors and Breakers of Advanced Glycation Endproducts (AGEs): A Review

Journal: Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume: 2
Page: 135-161
Author(s): S. Rahbar and J.L. Figarola

Drug Resistance and Apoptosis in Cancer Treatment: Development of New Apoptosis-Inducing Agents Active in Drug Resistant Malignancies

Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 2
Page: 387-401
Author(s): M. Tolomeo and D. Simoni

Disorders of Tetrahydrobiopterin Metabolism and their Treatment

Journal: Current Drug Metabolism
Volume: 3
Page: 123-131
Author(s): H. Shintaku

Physiology of Folic Acid in Health and Disease

Journal: Current Drug Metabolism
Volume: 3
Page: 211-223
Author(s): O. Stanger

Aspartic Proteinases in Disease: A Structural Perspective

Journal: Current Drug Targets
Volume: 3
Page: 155-173
Author(s): J. B. Cooper

Selective Agonists and Antagonists for Kainate Receptors

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 2
Page: 177-184
Author(s): Paola Conti, Marco De Amici and Carlo De Micheli

Role of Nitric Oxide in Ischemia and Reperfusion Injury

Journal: Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents
Volume: 1
Page: 1-13
Author(s): K. L. Chan

Nicotinic Agonists and Psychosis

Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 1
Page: 149-162
Author(s): J. K. Simosky, K. E. Stevens and R. Freedman

Preclinical Pharmacology of mGlu2 / 3 Receptor Agonists: Novel Agents for Schizophrenia?

Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 1
Page: 215-225
Author(s): Darryle D. Schoepp and Gerard J. Marek

Integrins as Novel Drug Targets for Overcoming Innate Drug Resistance

Journal: Current Cancer Drug Targets
Volume: 2
Page: 37-43
Author(s): Jason S. Damiano